Beijing Tiantan Biological Products Corp Ltd
SSE:600161

Watchlist Manager
Beijing Tiantan Biological Products Corp Ltd Logo
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Watchlist
Price: 21.26 CNY -3.8% Market Closed
Market Cap: 42B CNY
Have any thoughts about
Beijing Tiantan Biological Products Corp Ltd?
Write Note

Gross Margin
Beijing Tiantan Biological Products Corp Ltd

53.5%
Current
49%
Average
63.9%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
53.5%
=
Gross Profit
2.9B
/
Revenue
5.3B

Gross Margin Across Competitors

Country CN
Market Cap 42B CNY
Gross Margin
54%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 314.7B USD
Gross Margin
67%
Country US
Market Cap 157B USD
Gross Margin
60%
Country US
Market Cap 115.9B USD
Gross Margin
86%
Country US
Market Cap 112.2B USD
Gross Margin
78%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 133.6B AUD
Gross Margin
52%
Country US
Market Cap 82.6B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 34.5B EUR
Gross Margin
89%
No Stocks Found

Beijing Tiantan Biological Products Corp Ltd
Glance View

Market Cap
42B CNY
Industry
Biotechnology

Beijing Tiantan Biological Products Corp. Ltd. engages in the research and development, production and sale of biological products. The company is headquartered in Beijing, Beijing and currently employs 3,933 full-time employees. The Company’s primary products include preventive products, blood products and other biological products, such as the influenza A (H1N1) vaccines (split, inactivated),hepatitis B vaccines, poliomyelitis vaccines, measles-mump-rubella (MMR) vaccines, encephalitis B vaccines, influenza vaccinations, bacterial vaccines, human serum albumin (HSA) and intravenous immunoglobulin (IVIG), among others. The firm mainly distributes its products within domestic markets and to Hong Kong markets.

Intrinsic Value
26.91 CNY
Undervaluation 21%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
53.5%
=
Gross Profit
2.9B
/
Revenue
5.3B
What is the Gross Margin of Beijing Tiantan Biological Products Corp Ltd?

Based on Beijing Tiantan Biological Products Corp Ltd's most recent financial statements, the company has Gross Margin of 53.5%.